Two national 340B provider groups asked a federal judge Monday for permission to join HRSA in defending the agency’s 340B [...] …
Trade Association
Hospital groups slammed CMS’ recent proposal to slash Medicare Part B payments for 340B drugs, while a private oncologist group [...] …
Please Login or Become a Paid Subscriber to View this Content
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
A major hospital group on Wednesday asked Indiana-based drugmaker Eli Lilly to end its new 340B in-house pharmacy claims data [...] …
Please Login or Become a Paid Subscriber to View this Content
West Virginia state officials and several hospital groups recently urged a federal appeals court to reconsider a ruling against the [...] …
Please Login or Become a Paid Subscriber to View this Content
The Health Resources and Services Administration (HRSA) received more than 5,500 comments on its request for information (RFI) on a [...] …
Please Login or Become a Paid Subscriber to View this Content
The Health Resources and Services Administration (HRSA) has now received more than 1,100 identical public comments supporting 340B rebates tied to a template circulated by Patients Rising, a patient advocacy group that receives pharmaceutical industry funding.
The duplicate
…
An influential brand-name drug industry trade group recently filed the third legal challenge to Washington state’s new law prohibiting drugmakers [...] …
Please Login or Become a Paid Subscriber to View this Content
Patients Rising said it has stopped an outreach effort tied to the Health Resources and Services Administration’s (HRSA) 340B rebate [...] …
Please Login or Become a Paid Subscriber to View this Content
The Health Resources and Services Administration (HRSA) has published the first batch of stakeholder comments on its latest 340B rebate [...] …